Skip to main content
SpringerLink
Log in

Immunological and Hematological Response in COVID-19

  • Chapter
  • First Online:
Coronavirus Therapeutics – Volume I

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1352))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ACE2:

angiotensin-converting enzyme 2

aPTT:

activated partial thromboplastin time

ARDS:

acute respiratory distress syndrome

AT:

antithrombin

AUC:

area under curve

CAC:

COVID-19-associated coagulopathy

CRRT:

continuous renal replacement therapy

COVID-19:

Coronavirus Disease 2019

DIC:

disseminated intravascular coagulation

DFPP:

double filtration plasmapheresis

ESR:

erythrocyte sedimentation rate

FDP:

fibrin degradation products

GAGs:

glycosaminoglycans

ICU:

intensive care unit

MASP-2:

mannan-binding lectin-associated serine protease-2

MERS:

Middle East respiratory syndrome

NLR:

neutrophil to lymphocyte ratio

PAI-1:

plasminogen activator inhibitor-1

SARS-CoV-2:

severe acute respiratory syndrome coronavirus 2

TNF:

tumor necrosis factor

TPE:

therapeutic plasma exchange

UFH:

unfractionated heparin

VA-ECMO:

veno-arterial extracorporeal membrane oxygenation

VTE:

venous thromboembolism

References

  • Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A, Martucci G, Pilz S, Malle O (2020) Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr

    Google Scholar 

  • Arabi YM, Murthy S, Webb S (2020) COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med

    Google Scholar 

  • ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307(23):2526–2533. https://doi.org/10.1001/jama.2012.5669

    Article  CAS  Google Scholar 

  • Atri D, Siddiqi HK, Lang J, Nauffal V, Morrow DA, Bohula EA (2020) COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies. [Published online ahead of print, 2020 Apr 10]. JACC Basic Transl Sci 5(5):518–536

    Article  Google Scholar 

  • Avula A, Nalleballe K, Narula N et al (2020) COVID-19 presenting as stroke. Brain Behav Immun. S0889-1591(20)30685-1

    Google Scholar 

  • Bangash MN, Patel J, Parekh D (2020) COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol 5(6):529–530

    Article  Google Scholar 

  • Bar-Or D, Carrick M, Tanner A, Lieser MJ, Rael LT, Brody E (2018) Overcoming the Warburg effect: is it the key to survival in sepsis? J Crit Care 43:197–201

    Article  Google Scholar 

  • Basta M, Dalakas MC (1994) High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 94:1729–1735

    Article  CAS  Google Scholar 

  • Bates SM (2012) D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Semin Thromb Hemost 38(7):673–682

    Article  CAS  Google Scholar 

  • Bellani G et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315(8):788–800. https://doi.org/10.1001/jama.2016.0291

    Article  CAS  PubMed  Google Scholar 

  • Birra D, Benucci M, Landolfi L, Merchionda A, Loi G, Amato P, Licata G, Quartuccio L, Triggiani M, Moscato P (2020) COVID 19: a clue from innate immunity. Immunol Res 10:1–8. https://doi.org/10.1007/s12026-020-09137-5

    Article  CAS  Google Scholar 

  • Cao X (2020) COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol 20(5):269–270

    Article  CAS  Google Scholar 

  • Chang D, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, Sharma L (2020) Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA 323(11):1092–1093

    Article  Google Scholar 

  • Chen N et al (2020a) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/S0140-6736(20)30211-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q (2020b) Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. J Clin Invest. https://doi.org/10.1172/JCI137244

  • Cheng Y, Luo R, Wang K et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97(5):829–838

    Article  CAS  Google Scholar 

  • Chousterman BG, Swirski FK, Weber GF (2017) Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol 39:517–528

    Article  CAS  Google Scholar 

  • Ciceri F et al (2020) Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. Online ahead of print

    Google Scholar 

  • Cugno M et al (2020) Complement activation in patients with COVID-19: a novel therapeutic target. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2020.05.006. S0091-6749(20)30650-3

  • Cummings MJ et al (2020) Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. medRxiv. Apr 20:2020.04.15.20067157

    Google Scholar 

  • Diao B, Wang C, Wang R, Feng Z, Tan Y, Wang H et al (2020) Human kidney is a target for novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection. medRxiv. 2020.03.04.20031120

    Google Scholar 

  • Flisiak R, Horban A, Jaroszewicz J, Kozielewicz D, Pawłowska M, Parczewski M, Piekarska A, Simon K, Tomasiewicz K, Zarębska-Michaluk D (2020) Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020. Pol Arch Intern Med 130(4):352–357

    PubMed  Google Scholar 

  • Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY (2020) A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect 9(1):558–570

    Article  CAS  Google Scholar 

  • Gandhi A, Goerlinger K (n.d.) Coagulopathy in COVID-19: connecting the dots together. J Card Crit Care:TSS 2020. Online ahead of print

    Google Scholar 

  • Gattinoni L, Pesenti A, Avalli L, Rossi F, Bombino M (1987) Pressure–volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. Am Rev Respir Dis 136(3):730–736

    Article  CAS  Google Scholar 

  • Gattinoni L, Meissner K, Marini JJ (2020a) The baby lung and the COVID-19 era. Intensive Care Med 25:1–3. https://doi.org/10.1007/s00134-020-06103-5

    Article  CAS  Google Scholar 

  • Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D (2020b) COVID-19 does not lead to a “Typical” acute respiratory distress syndrome. Am J Respir Crit Care Med 201(10):1299–1300. https://doi.org/10.1164/rccm.202003-0817LE

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gattinoni L, Chiumello D, Rossi S (2020c) COVID-19 pneumonia: ARDS or not? Crit Care 24(1):154. https://doi.org/10.1186/s13054-020-02880-z

    Article  PubMed  PubMed Central  Google Scholar 

  • Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, Camporota L (2020d) COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 46(6):1099–1102. https://doi.org/10.1007/s00134-020-06033-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR et al (2018) Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio 9:e01753–e01718

    Article  Google Scholar 

  • Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS (2020) China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032

  • Hess DC, Eldahshan W, Rutkowski E (2020) COVID-19-related stroke. Transl Stroke Res 11(3):322–325

    Article  CAS  Google Scholar 

  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506

    Article  CAS  Google Scholar 

  • Ji HL, Zhao R, Matalon S, Matthay MA (2020) Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility. Physiol Rev 100(3):1065–1075

    Article  Google Scholar 

  • Ko JH, Park GE, Lee JY, Lee JY, Cho SY, Ha YE, Kang CI, Kang JM, Kim YJ, Huh HJ, Ki CS, Jeong BH, Park J, Chung CR, Chung DR, Song JH, Peck KR (2016) Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients. J Infect 73(5):468–475

    Article  Google Scholar 

  • Kruttgen A, Rose-John S (2012) Interleukin-6 in sepsis and capillary leakage syndrome. J Interferon Cytokine Res 32:60–65

    Article  Google Scholar 

  • Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, Ko WC, Hsueh PR (2020) Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect. https://doi.org/10.1016/j.jmii.2020.02.012

  • Li T, Qiu Z, Zhang L, Han Y, He W, Liu Z, Ma X, Fan H, Lu W, Xie J, Wang H, Deng G, Wang A (2004) Significant changes of peripheral t lymphocyte subsets in patients with severe acute respiratory syndrome. J Infect Dis 189:648–651

    Article  Google Scholar 

  • Li MY, Li L, Zhang Y, Wang XS (2020a) Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 9(1):45

    Article  Google Scholar 

  • Li Q, Ding X, Xia G, Geng Z, Chen F, Wang L, Wang Z (2020b) A simple laboratory parameter facilitates early identification of COVID-19 patients. medRxiv. https://doi.org/10.1101/2020.02.13.20022830

  • Lin L, Lu L, Cao W, Li T (2020) Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect:1–14. https://doi.org/10.1080/22221751.2020.1746199

  • Lippi G, Mattiuzzi C (2020) Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther. https://doi.org/10.1016/j.htct.2020.03.001

  • Lippi G, Plebani M, Henry BM (2020) Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 506:145–148

    Article  CAS  Google Scholar 

  • Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG (2020a) Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). https://doi.org/10.1097/CM9.0000000000000744

  • Liu J, Li S, Liu J, Liang B, Wang X, Wang H et al (2020b) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. medRxiv. https://doi.org/10.1101/2020.02.16.20023671

  • Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C et al (2020c) Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage. medRxiv. https://doi.org/10.1101/2020.02.10.20021584

  • Ludvigsson JF (2020 Jun) Systematic review of covid-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 109(6):1088–1095

    Article  CAS  Google Scholar 

  • Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J (2020) Tocilizumab treatment in covid-19: a single center experience. J Med Virol

    Google Scholar 

  • Marini JJ, Gattinoni L (2020) Management of COVID-19 respiratory distress. JAMA. https://doi.org/10.1001/jama.2020.6825

  • Markus HS, Brainin M (2020) COVID-19 and stroke – a global World Stroke Organization perspective. Int J Stroke 15(4):361–364

    Article  Google Scholar 

  • Martín Giménez VM, Inserra F, Tajer CD, Mariani J, Ferder L, Reiter RJ, Manucha W (2020) Lungs as target of COVID-19 infection: protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci 254:117808. https://doi.org/10.1016/j.lfs.2020.117808

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Martucci G, McNally D, Parekh D et al (2019) Trying to identify who may benefit most from future vitamin D intervention trials: a post hoc analysis from the VITDAL-ICU study excluding the early deaths. 23:200

    Google Scholar 

  • Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) Hlh across speciality collaboration UK. Covid-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034

    Article  CAS  Google Scholar 

  • Michot JM, Albiges L, Chaput N, Saada V, Pommeret F, Griscelli F, Balleyguier C, Besse B, Marabelle A, Netzer F, Merad M, Robert C, Barlesi F, Gachot B, Stoclin A (2020) Tocilizumab, an anti-il6 receptor antibody, to treat covid-19-related respiratory failure: a case report. Ann Oncol

    Google Scholar 

  • Muxel JM, Pires-Lapa MA, Morteiro AW, Cecon E, Tamura EK, Flaeten-Winter LM, Markus RP (2012) NF-kB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene. PLoS One

    Google Scholar 

  • Nasab MG, Saghazadeh A, Rezaei N (2020) SARS-CoV-2-A tough opponent for the immune system. Arch Med Res. https://doi.org/10.1016/j.arcmed.2020.05.020. May 30:S0188-4409(20)30749-9

  • Nicin L, Abplanalp WT, Mellentin H et al (2020) Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts. Eur Heart J 41(19):1804–1806

    Article  CAS  Google Scholar 

  • Northrop-Clewes CA (2008) Interpreting indicators of iron status during an acute phase response-lessons from malaria and human immunodeficiency virus. Ann Clin Biochem 45(1):18–32

    Article  CAS  Google Scholar 

  • Oxley TJ, Mocco J, Majidi S et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382(20):e60

    Article  Google Scholar 

  • Pan XW, Xu D, Zhang H, Zhou W, Wang LH, Cui XG (2020) Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 46(6):1114–1116

    Article  CAS  Google Scholar 

  • Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A (2020) Hypercoagulability of COVID-19 patients in intensive care unit. a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 17. https://doi.org/10.1111/jth.14850

  • Patriquin CJ, Kuo KHM (2019) Eculizumab and beyond: the past, present, and future of complement therapeutics. Transfusion Med Rev 33:256–265

    Article  Google Scholar 

  • Piacente C, Martucci G, Miceli V, Pavone G, Papeo A, Occhipinti G, Panarello G, Lorusso R, Tanaka K, Arcadipane A (2020) A narrative review of antithrombin use during veno-venous extracorporeal membrane oxygenation in adults: rationale, current use, effects on anticoagulation, and outcomes. Perfusion 267659120913803

    Google Scholar 

  • Reiter RJ et al (2020) Melatonin inhibits COVID-19-induced cytokine storm by reversing aerobic glycolysis in immune cells: a mechanistic analysis. Med Drug Discov 6:100044. https://doi.org/10.1016/j.medidd.2020.100044

    Article  PubMed  PubMed Central  Google Scholar 

  • Shrestha GS et al (2020) Precision medicine for COVID-19: a call for better clinical trials. Crit Care

    Google Scholar 

  • Song H, Seddighzadeh B, Cooperberg MR, Huang FW (2020) Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells [Published online ahead of print, 2020 May 6]. Eur Urol. https://doi.org/10.1016/j.eururo.2020.04.065

  • Sun J, Aghemo A, Forner A, Valenti L (2020) COVID-19 and liver disease. Liver Int 40(6):1278–1281

    Article  CAS  Google Scholar 

  • Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ, Wang Q, Miao H (2020a) Lymphopenia predicts disease severity of covid-19: a descriptive and predictive study. Signal Transduct Target Ther 5:33

    Article  CAS  Google Scholar 

  • Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ et al (2020b) Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther 5:33. https://doi.org/10.1038/s41392-020-0148-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tang N, Bai H, Chen X, Gong J, Li D, Sun Z (2020a) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost

    Google Scholar 

  • Tang X et al (2020b) Comparison of hospitalized patients with acute respiratory distress syndrome caused by covid-19 and h1n1. Chest

    Google Scholar 

  • Tang N, Li D, Wang X, Sun Z (2020c) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844–847

    Article  CAS  Google Scholar 

  • Taylor FB Jr, Toh CH, Hoots WK et al (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation On behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost 86:1327–1330

    Article  CAS  Google Scholar 

  • Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18(5):1023–1026

    Article  CAS  Google Scholar 

  • Tripodi A (2011) D-dimer testing in laboratory practice. Clin Chem 57(9):1256–1262

    Article  CAS  Google Scholar 

  • van der Poll T, Opal SM (2008) Host-pathogen interactions in sepsis. Lancet Infect Dis 8:32–43

    Article  Google Scholar 

  • Wang J et al (2020a) Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. https://doi.org/10.1002/JLB.3COVR0520-272R

  • Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020b) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585

  • Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Int Med

    Google Scholar 

  • Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF, Cai HL, Qiu YQ, Li LJ (2020) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. https://doi.org/10.1136/bmj.m606

  • Yao Z, DuBois DC, Almon RR, Jusko WJ (2008) Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats. J Pharm Sci 97(7):2820–2832

    Article  CAS  Google Scholar 

  • Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect 80(6):607–613

    Article  CAS  Google Scholar 

  • Yuki K, Fujiogi M, Koutsogiannaki S (2020) COVID-19 pathophysiology: A review. Clin Immunol. 215:108427. https://doi.org/10.1016/j.clim.2020.108427

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020a) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 46(4):586–590

    Article  CAS  Google Scholar 

  • Zhang C, Wu Z, Li JW, Zhao H, Wang GQ (2020b) The cytokine release syndrome (crs) of severe covid-19 and interleukin-6 receptor (il-6r) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 105954

    Google Scholar 

  • Zhang C, Shi L, Wang FS (2020c) Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 5(5):428–430

    Article  Google Scholar 

  • Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD (2020d) Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. https://doi.org/10.1111/all.14238

  • Zhang B, Zhou X, Zhu C, Feng F, Qiu Y, Feng J et al (2020e) Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19. medRxiv. https://doi.org/10.1101/2020.03.12.20035048

  • Zhang H, Wang X, Fu Z, Luo M, Zhang Z, Zhang K et al (2020f) Potential factors for prediction of disease severity of COVID-19 patients. medRxiv. https://doi.org/10.1101/2020.03.20.20039818

  • Zhu N et al (2020) A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382(8):727–733. https://doi.org/10.1056/NEJMoa2001017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Conflicts of Interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Author notes

  1. Artur Słomka and Gennaro Martucci contributed equally with all other contributors.

Authors and Affiliations

  1. Department of Pathophysiology, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland

    Artur Słomka & Ewa Żekanowska

  2. Department of Anesthesia and Intensive Care, IRCCS-ISMETT, Palermo, Italy

    Gennaro Martucci

  3. Cardiac Surgery Unit, IRCCS-ISMETT, Palermo, Italy

    Giuseppe Maria Raffa

  4. Wessex Cardiothoracic Centre, University Hospital Southampton, Southampton, UK

    Pietro Giorgio Malvindi

  5. Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands

    Roberto Lorusso

  6. Cardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands

    Roberto Lorusso & Mariusz Kowalewski

  7. Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior, Centre of Postgraduate Medical Education, Warsaw, Poland

    Piotr Suwalski & Mariusz Kowalewski

  8. Thoracic Research Centre, Collegium Medicum, Nicolaus Copernicus University, Innovative Medical Forum, Bydgoszcz, Poland

    Mariusz Kowalewski

Authors
  1. Artur Słomka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gennaro Martucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Maria Raffa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pietro Giorgio Malvindi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ewa Żekanowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roberto Lorusso
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Piotr Suwalski
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mariusz Kowalewski
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. President & CEO, NampEVA BioTherapeutics LLC, Dover, DE, USA

    Alexzander A. A. Asea

  2. Department of Medicine and Precision Therapeutics Proteogenomics Diagnostic Center Eleanor N. Dana Cancer Center, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

    Punit Kaur

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Słomka, A. et al. (2021). Immunological and Hematological Response in COVID-19. In: Asea, A.A.A., Kaur, P. (eds) Coronavirus Therapeutics – Volume I. Advances in Experimental Medicine and Biology, vol 1352. Springer, Cham. https://doi.org/10.1007/978-3-030-85109-5_5

Download citation

Publish with us

Policies and ethics

Search

Navigation